Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05265715 · ClinicalTrials.gov registry record · NA
A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05265715 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 14 participants.
The verdict
NCT05265715, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The scientific premise for this study is the known impact of overweight/obesity on breast cancer risk and outcomes, the association between advanced glycation end-products (AGE) and high fat, highly processed foods common in Western diets, and the preclinical evidence suggesting a link between AGE and breast cancer independent of weight. The association between dietary and serum AGE in breast cancer survivors and prognosis has not been previously evaluated. However, preclinical studies suggest that AGE may represent a novel, lifestyle-linked, modifiable, prognostic biomarker, which could be targeted through lifestyle (diet and exercise) and/or pharmaceutical interventions to improve breast cancer prognosis. The proposed study will pave the way for a large scale randomized controlled trial to evaluate the impact of a low AGE diet on weight (BMI), known (IL-6 and CRP) and novel (AGE and RAGE) prognostic biomarkers, and ultimately on breast cancer prognosis.
Interventions
- PROCEDURE Research blood draw
- OTHER Low AGE diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-10-14 |
| Est. Completion | 2024-03-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05265715
The ClinicalTrials.gov registry entry for NCT05265715 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Research blood draw is the first listed.
NCT05265715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05265715 about?
NCT05265715 is a clinical study titled "A Low AGE (Advanced Glycation End-product) Dietary Intervention for Breast Cancer Survivors". The scientific premise for this study is the known impact of overweight/obesity on breast cancer risk and outcomes, the association between advanced glycation end-products (AGE) and high fat, highly processed foods common in Western diets, and the preclinical evidence suggesting a link between AGE a...
What is the current status of trial NCT05265715?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-10-14. Estimated completion is 2024-03-22.
What interventions are being tested in trial NCT05265715?
The interventions under investigation include: Research blood draw (PROCEDURE), Low AGE diet (OTHER).
Who is sponsoring clinical trial NCT05265715?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.